Cedars-Sinai Gastroenterologists Share Latest Research and Honors at ACG 2022 Scientific Meeting

Newswise – LOS ANGELES (October 19, 2022) – Cedars-Sinai doctors and scientists will share the results of new research aimed at improving treatment of digestive diseases during the International Meeting of the American College of Gastroenterology (ACG). The clinical conference will take place October 21-26 in Charlotte, North Carolina, and is available for virtual and in-person attendance.

Twenty-five presentations of studies led or co-authored by the Cedars-Sinai investigators cover a wide range of research in digestive disorders, including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and bacterial overgrowth in the small intestine (SIBO). Colorectal cancer screening and virtual reality for symptom management.

In addition to the research highlighted at the conference, two multicenter studies highlighting the work of Cedars-Sinai scientists have been honored with the ACG Governors Award for Excellence in Clinical Research and a Presidential Poster Award.

during the conference, Sinai rice Experts will be available to comment on a wide range of clinical and scientific developments in the field of gastroenterology and patient care. Interviews with scholars attending the conference can be arranged in person or remotely. For a complete list of Cedars-Sinai poster presentations or for interviews, please contact Laura Coverson by phone at 310-562-1112 or by email: [email protected].

Ban policy for 2022 ACG: All papers submitted in ACG 2022 are strictly prohibited until 12 noon EST on Sunday 23 October 2022

Cedars-Sinai Research Highlights at ACG 2022 – All Times EDT

a poster: Relationship between fecal elimination of SARS-Cov-2 virus, microbiome diversity and enteritis. A multicenter study. Andres Yarror, MDgastroenterology and associate professor of medicine at Cedars-Sinai.

Monday October 24, from 10am to 12pm

a poster: Symptomatic response to antibiotics in patients with bacterial overgrowth of the small intestine: a systematic review and meta-analysis. A multicenter study. Mark Pimentel, MDCEO of a company Medically related science and technology programAnd the Ali Rezaei, MDmedical director of GI Motility.
Monday October 24, from 10am to 12pm

AGC Governors Award
Oral: Virtual reality improves symptoms of functional dyspepsia: results of a randomized, controlled, double-blind pilot study. A multicenter study. Mayo Clinic, Jacksonville, Florida, and Cedars-Sinai. Brennan Spiegel, MD, MSHSDirector of Health Services Research in Cedars Sinai. Oral presentation by David Cangemi, MD, Mayo Clinic.
Monday October 24, 8:24 am

AGC Presidential Poster Award

a poster: Clinical utility of a precision-guided dosing instrument for infliximab during prophylactic treatment of inflammatory bowel disease. A multicenter study. Shirvin Rabizadeh, MD, MBAMD, director, pediatric gastroenterology and inflammatory bowel disease, and chief of pediatrics at Guerin Children’s, Jill Melmed, MDdirector of clinical research for inflammatory bowel disease.
Monday October 24, 3-5 p.m.

a poster: Is fecal immunohistochemical test (FIT) the answer to the increase in colorectal cancer (CRC) screening in the Filipino community? Results from a joint analysis survey.
Christopher F. Mario, MD, MSHPMAssistant Professor of Medicine in Cedars-Sinai.
Monday October 24, 3-5 p.m.

a poster: Evaluation of multiple dose regimens of proton pump inhibitors (PPIs) for the treatment of gastroesophageal reflux disease (GERD): a systematic review and meta-analysis. Gillian Gresham, Ph.D.Research Scientist, Rice Sinai and Brennan Spiegel, MD, MSHSDirector of Health Services Research in Cedars Sinai.
Tuesday, October 25, from 10 a.m. to 12 p.m.

Leave a Comment